Tissue classification in a canine model of Duchenne Muscular Dystrophy using quantitative MRI parameters

Duchenne Muscular Dystrophy (DMD) is a genetic disorder caused by dystrophin protein deficiency. Muscle biopsy is the gold standard to determine the disease severity and progression. MRI has shown potential for monitoring disease progression or assessing the treatment effectiveness. In this study, multiple quantitative MRI parameters were used to classify the tissue components in a canine model of DMD disease using histoimmunochemistry analysis as a “ground truth”. Results show that multiple MRI parameters may be used to reliably classify the muscular tissue and generate a high-resolution tissue type maps, which can be used as potential non-invasive imaging biomarkers for the DMD.

[1]  G H Glover,et al.  Three‐point dixon technique for true water/fat decomposition with B0 inhomogeneity correction , 1991, Magnetic resonance in medicine.

[2]  J. Kornegay,et al.  Localized MRI and histological image correlation in a canine model of duchenne muscular dystrophy , 2016, 2016 38th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC).

[3]  J. Morgan,et al.  Duchenne's muscular dystrophy: animal models used to investigate pathogenesis and develop therapeutic strategies , 2003, International journal of experimental pathology.

[4]  C. Senesac,et al.  Assessment of intramuscular lipid and metabolites of the lower leg using magnetic resonance spectroscopy in boys with Duchenne muscular dystrophy , 2014, Neuromuscular Disorders.

[5]  Bostjan Likar,et al.  A review of 3D/2D registration methods for image-guided interventions , 2012, Medical Image Anal..

[6]  P. Carlier,et al.  Characterization of dystrophic muscle in golden retriever muscular dystrophy dogs by nuclear magnetic resonance imaging , 2007, Neuromuscular Disorders.

[7]  Krista Vandenborne,et al.  Chemical shift‐based MRI to measure fat fractions in dystrophic skeletal muscle , 2014, Magnetic resonance in medicine.

[8]  R. Finkel,et al.  MRI/MRS evaluation of a female carrier of Duchenne muscular dystrophy , 2012, Neuromuscular Disorders.

[9]  Daniel C. Alexander,et al.  Camino: Open-Source Diffusion-MRI Reconstruction and Processing , 2006 .

[10]  M. Versluis,et al.  Quantitative MRI and strength measurements in the assessment of muscle quality in Duchenne muscular dystrophy , 2014, Neuromuscular Disorders.

[11]  Martin Styner,et al.  Characteristics of magnetic resonance imaging biomarkers in a natural history study of golden retriever muscular dystrophy , 2014, Neuromuscular Disorders.

[12]  B. Rutt,et al.  Rapid combined T1 and T2 mapping using gradient recalled acquisition in the steady state , 2003, Magnetic resonance in medicine.